Clinical Trial

SBRT for Ventricular Arrhythmia

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to demonstrate the safety and efficacy of STAR (Stereotactic Antiarrhythmic Radiotherapy) in patients with VT (ventricular tachycardia) who are unresponsive to standard treatments. Additionally, the planned study aims to provide further insights into the effects of STAR on VT burden, ICD interventions, and insights regarding late toxicities, particularly those related to the heart, which are currently not well understood.
Trial Details
NCT Number NCT06411392
Lead Sponsor Medical University of Graz
Conditions Ventricular Arrythmia
Enrollment 10 participants
Start Date 2024-03-01
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2024-05-13